Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenues	$ 13,088	$ 18,348	$ 23,824	$ 39,887
Cost of revenues	7,855	11,726	14,438	24,507
Gross profit	5,233	6,622	9,386	15,380
Operating expenses:
General and administrative	6,124	9,492	14,990	19,769
Sales and marketing	3,078	9,723	6,431	21,354
Research and development	2,745	7,770	5,635	16,315
Total operating expenses	11,947	26,985	27,056	57,438
Operating loss	(6,714)	(20,363)	(17,670)	(42,058)
Other (expense) income:
Interest expense, net	(52)	(203)	(2,864)	(429)
Common stock warrant liability adjustment	(1,629)	8,811	283	1,935
Other (expense) income, net	(67)	63	(78)	109
Total other (expense) income, net	(1,748)	8,671	(2,659)	1,615
Loss before income tax provision	(8,462)	(11,692)	(20,329)	(40,443)
Income tax provision	(5)	(26)	(5)	(33)
Net loss and comprehensive loss	(8,467)	(11,718)	(20,334)	(40,476)
Accretion on Series A convertible preferred stock	(1,326)	0	(1,979)	0
Net loss attributable to common stockholders, basic	(9,793)	(11,718)	(22,313)	(40,476)
Net loss attributable to common stockholders, diluted	$ (9,793)	$ (11,718)	$ (22,313)	$ (40,476)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (1.19)	$ (1.48)	$ (2.73)	$ (5.12)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (1.19)	$ (1.48)	$ (2.73)	$ (5.12)
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic (in shares)	8,213,247	7,915,156	8,162,102	7,899,959
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, diluted (in shares)	8,213,247	7,915,156	8,162,102	7,899,959